Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the fourth quarter and year ending December 31, 2013 on Thursday, February 13, 2014, after the U.S. financial markets close.
Management will provide an update on the company, discuss fourth quarter and year-end 2013 results, and discuss expectations for the future via conference call on Thursday, February 13, 2014 at 4:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
